GE HealthCare Q4 revenue $5.2B (+5% organic); Adj EPS $1.18; guides FY2024 Adj EPS $4.20-4.35

GE HealthCare Technologies Inc.

2023-FY EPS reported $3.03 revenue$19,552,000,000

Q4 revenue $5.2B (+5% organic); net income $403M vs $554M; Adj EBIT margin 16.1% vs 17.1%.
FY 2023 revenue $19.6B (+8% organic); net income $1.6B; Adj EPS $3.93 vs $4.63 prior year.
Free cash flow Q4 $956M; repaid $850M debt in Q4 and $150M in Jan 2024.
FY2024 guidance: organic rev ~4% growth, Adj EBIT margin 15.6-15.9%, Adj EPS $4.20-4.35, FCF ~$1.8B.
Segment: Imaging +4% organic, Ultrasound -2%, Patient Care +4%, Pharma Diagnostics +23%.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

GE HealthCare Technologies Inc. reported financial results for the fourth quarter and fiscal year ended December 31, 2023.

Period: the fourth quarter and fiscal year ended December 31, 2023
Result: reported results

Exact text from the filing

On February 6, 2024 , GE HealthCare Technologies Inc. (“GE HealthCare”) issued a press release announcing its fourth quarter and fiscal year ended December 31, 2023 financial results.

View on SEC.gov

Browse all earnings releases →

GE HealthCare Technologies Inc. filing history →

Source: SEC EDGAR

accession 0001932393-24-000012

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.